TSG101: Tumor Susceptibility 101 Gene and Its Role in Cancer and Cellular Trafficking

Comprehensive biomedical overview of TSG101, including genomic data, expression, mutations, and clinical significance.

Gene Information Card

Symbol TSG101
Full Name Tumor Susceptibility 101
Gene Type Protein coding
Chromosomal Location 11p15.1
NCBI Gene ID 7251 ncbi.nlm.nih.gov/gene/7251
Ensembl ID ENSG00000074319
UniProt ID Q99816
OMIM ID 601387
HGNC ID 12371
Aliases TSG10, VPS23, ESCRT-I subunit

Description

TSG101 (Tumor Susceptibility 101) encodes a protein that is a core component of the endosomal sorting complexes required for transport (ESCRT-I) machinery. It plays a critical role in multivesicular body (MVB) biogenesis, ubiquitin-dependent protein sorting, and cytokinesis. TSG101 also functions in transcriptional regulation and cell cycle control. Loss or dysregulation of TSG101 is implicated in tumorigenesis, particularly in breast and prostate cancers, as well as in viral budding and neurodegenerative disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer TSG101 frameshift mutations and reduced expression lead to genomic instability and altered cell proliferation. PMID: 10557339; COSMIC
Prostate cancer TSG101 overexpression and aberrant splicing contribute to tumor progression and metastasis. PMID: 12007233; COSMIC
Endometrial cancer TSG101 mutations and copy number alterations are recurrent in endometrial tumors. COSMIC; TCGA
Colorectal cancer TSG101 downregulation correlates with poor prognosis and increased invasiveness. PMID: 19029980

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 18.5 High
Lymph node 12.3 Medium
Breast 8.7 Medium
Prostate 7.2 Medium
Brain 4.1 Low
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 15.2 High expression
PC3 (prostate cancer) 11.8 Moderate expression
HeLa (cervical cancer) 9.5 Moderate expression
HEK293 (embryonic kidney) 7.3 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.1% Loss of start codon; likely loss of function
c.209_210insA (p.Gln70fs) Frameshift insertion 0.2% Truncation; loss of ESCRT-I function
c.532C>T (p.Arg178Trp) Missense 0.1% Altered protein stability; uncertain significance
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations in TSG101 lead to truncated proteins that disrupt ESCRT-I complex assembly and MVB sorting, promoting tumorigenesis.

Gain of Function (GOF)

No well-established gain-of-function mutations reported; overexpression in some cancers may confer proliferative advantage.

Dominant Negative (DN)

Certain missense mutations (e.g., in the UEV domain) can interfere with wild-type TSG101 function, acting in a dominant-negative manner.

Pathways

• ESCRT-mediated multivesicular body sorting (Reactome: R-HSA-917729)
• Endosomal sorting complex required for transport (ESCRT) (KEGG: hsa04144)
• Autophagy (KEGG: hsa04140)

Protein Summary

The TSG101 protein (Q99816) is a 380-amino acid component of the ESCRT-I complex. It contains an N-terminal ubiquitin E2 variant (UEV) domain that binds ubiquitinated cargo, a proline-rich region, and a C-terminal steadiness box. TSG101 is essential for sorting ubiquitinated membrane proteins into intraluminal vesicles of multivesicular bodies, thereby regulating receptor downregulation, cytokinesis, and viral budding. Its structure and interactions are critical for maintaining cellular homeostasis.

Related Products

Product name Cat.No. Species Gene ID
No Data
Contact Us
*
*
*
How did you hear about us: